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Pomparative Accuracy of Real-Time
yocardial Contrast Perfusion Imaging
nd Wall Motion Analysis During
obutamine Stress Echocardiography
or the Diagnosis of Coronary Artery Disease
bdou Elhendy, MD, PHD, FACC,* Edward L. O’Leary, MD, FACC,* Feng Xie, MD,*
nna C. McGrain, BSN, RN,* James R. Anderson, PHD,† Thomas R. Porter, MD, FACC*
maha, Nebraska
OBJECTIVE This study sought to compare the accuracy of myocardial contrast echocardiography (MCE)
and wall motion analysis (WMA) during submaximal and peak dobutamine stress echocar-
diography (DSE) for the diagnosis of coronary artery disease (CAD).
BACKGROUND The relative merits of MCE and WMA for the detection of CAD during DSE have not been
studied in a large number of patients.
METHODS We studied 170 patients who underwent dobutamine (up to 50 g/kg/min)-atropine stress
testing and coronary angiography. The WMA and MCE (using repeated boluses of Optison
[Mallinckrodt, St. Louis, Missouri] or Definity [Bristol-Myers Squibb, New York,
New York]) were performed at rest, at intermediate stress (65% to 75% of maximal heart
rate), and at peak stress. The diagnosis of CAD (50% stenosis in 1 coronary artery) was
based on reversible wall motion and perfusion abnormalities.
RESULTS Coronary artery disease was detected in 127 (75%) patients. Sensitivity of MCE was higher
than that of WMA at maximal stress (91% vs. 70%; p  0.001) and at intermediate stress
(84% vs. 20%; p  0.0001). Specificity was lower for MCE compared with WMA (51% vs.
74%; p  0.01). Overall accuracy was higher for MCE than for WMA (81% vs. 71%; p 
0.01). Sensitivity for detection of CAD based on abnormalities in 2 vascular regions was
higher for MCE than for WMA (67% vs. 28%; p  0.01).
CONCLUSIONS The majority of inducible perfusion abnormalities occur at an intermediate phase of the stress
test, without wall motion abnormalities. Myocardial contrast echocardiography provides
better sensitivity than WMA, particularly in patients with submaximal stress and in
identifying patients with multivessel CAD. (J Am Coll Cardiol 2004;44:2185–91) © 2004
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.08.059by the American College of Cardiology Foundation
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sobutamine stress echocardiography (DSE) is a widely
sed technique for the diagnosis of coronary artery disease
CAD). However, pooled data have shown that the sensi-
ivity of wall motion analysis (WMA) is modest, particularly
n patients with single-vessel CAD (1–7). Although pa-
ients with multivessel CAD often demonstrate wall motion
bnormalities during DSE, abnormalities are often detected
n a single vascular region, with underestimation of the
xtent of CAD (1).
The induction of new wall motion abnormalities during
SE is largely dependent on achieving an adequate stress
evel. Failure to achieve the predicted heart rate has been
ssociated with false negative tests (1,5,8). Experimental
tudies have shown that myocardial perfusion abnormalities
recede wall motion abnormalities during dobutamine in-
usion and, therefore, assessment of myocardial perfusion
ay potentially improve the sensitivity of DSE in patients
ith submaximal stress (9). Despite evidence from animal
From the *Department of Internal Medicine, Section of Cardiology, and the
Department of Biostatistics, University of Nebraska Medical Center, Omaha,
ebraska.c
Manuscript received May 6, 2004; revised manuscript received August 16, 2004,
ccepted August 25, 2004.tudies, the temporal sequence of perfusion and functional
bnormalities in the ischemic cascade has not been ade-
uately studied in humans.
Myocardial contrast echocardiography (MCE) is a newly
ntroduced technique for the evaluation of myocardial per-
usion in patients with suspected CAD (10–21). Real-time
maging using low mechanical index pulse sequence
chemes enhances the detection of microbubbles and re-
uces microbubbles’ destruction. This permits the real-time
dentification of perfusion abnormalities during stress echo-
ardiography (21). The aims of this prospective study were:
) to compare the accuracies of MCE and WMA during
SE for the overall and regional diagnosis of CAD; 2) to
tudy the impact of achieved stress level on the accuracy of
oth methods; and 3) to document the temporal sequence of
erfusion and wall motion abnormalities during myocardial
schemia in a large number of patients with suspected CAD.
ETHODS
e prospectively studied 1,318 patients with known or
uspected CAD, referred for DSE, by real-time MCE in
onjunction with WMA in our institution between January
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oronary angiography within one month of DSE. Nine (5%)
atients were excluded because of contrast attenuation
uring DSE that precluded adequate analysis of wall motion
nd perfusion. The final population, therefore, consisted of
70 patients. Mean age was 60  12 years. There were 71
42%) women. All patients gave an informed consent to
ndergo the stress test. The protocol of this study was
pproved by the Institutional Review Board of the Univer-
ity of Nebraska Medical Center. Clinical data are presented
n Table 1.
obutamine stress test. Patients were instructed to dis-
ontinue beta-blockers 24 h before the stress test. Dobut-
mine was infused at a starting dose of 5 g/kg/min for 3 to
min, followed by 10 g/kg/min for 3 to 5 min. The
obutamine dose was increased by 10 g/kg/min every
min up to a maximum dose of 50 g/kg/min. Atropine
up to 2 mg) was administered intravenously if 85% of
aximal predicted heart rate (220  age) was not achieved.
nd points were achievement of target heart rate, maximal
ose of dobutamine and atropine, hypertension (blood
ressure 240/120 mm Hg), symptomatic decrease in
ystolic blood pressure, symptomatic or sustained ventricular
r supraventricular tachycardia, ST-segment depression 2
m in electrocardiogram (ECG) leads without resting
T-segment depression, 2 mm ST-segment elevation in
CG leads without Q waves, severe angina, and any
ntolerable adverse effect considered to be the result of
obutamine or atropine. Metoprolol (1 to 5 mg) was used
ntravenously to reverse the side effects of dobutamine if
Abbreviations and Acronyms
CAD  coronary artery disease
CI  confidence interval
DSE  dobutamine stress echocardiography
ECG  electrocardiogram
LAD  left anterior descending
LCx  left circumflex
MCE  myocardial contrast echocardiography
RCA  right coronary artery
WMA  wall motion analysis
able 1. Clinical Data of the Study Patients
Clinical Parameters Number (%)
easons for referral
Evaluation of chest pain 108 (64%)
Multiple risk factors 14 (8%)
Peri-operative risk assessment 48 (28%)
revious myocardial infarction 39 (23%)
iabetes mellitus 23 (14%)
ypertension 124 (73%)
ypercholesterolemia 107 (63%)
igarette smoking 61 (36%)
eta blockers 137 (81%)
alcium channel blockers 57 (34%)njection fraction 60 14%hese did not revert quickly after termination of the
nfusion.
chocardiographic imaging. The contrast agents used for
he study were a perfluorocarbon-containing, albumin-
oated microbubble (Optison, Mallinckrodt, St. Louis,
issouri) in 140 patients and a lipid-encapsulated,
erfluoropropane-filled microbubble (Definity, Bristol-
yers Squibb, New York, New York) in 30 patients.
maging was performed using commercially available ultra-
ound scanners (Philips Agilent 5500 B.2 and Philips ATL
DI 5000 10.3.5, Philips Medical Systems, Bothell, Wash-
ngton; or Siemens Acuson Sequoia 6.0, Siemens Medical
olutions, Malvern, Pennsylvania), equipped with low me-
hanical index, real-time pulse sequence schemes. Imaging
as performed by the use of pulse-inversion Doppler
Philips ATL) in 109 (64%) patients, contrast pulse se-
uencing (Siemens Acuson Sequoia) in 30 (18%) patients,
nd power modulation (Philips Agilent) in 31 (18%) pa-
ients. The equipment was adjusted to achieve maximal
onlinear signal from contrast. Mechanical indexes were set
o 0.3 and frame rate to 25 Hz. Time-gain compensa-
ion and two-dimensional gain settings were adjusted to
uppress signals from the myocardium before contrast in-
ection. Images from apical views (four-, two-, and three-
hamber) were obtained and digitized at rest; at an inter-
ediate stage of stress, defined as achievement of 65% to
5% of maximal heart rate predicted for age and at maximal
tress after the patients had achieved 85% predicted
aximum heart rate or a test end point.
After optimization of the settings, a 0.2- to 0.3-ml
alibration dose of Optison or a 0.1- to 0.15-ml dose of
efinity followed by a saline flush was given. Setting
orrections were made to optimize gain and minimize any
issue nonlinear signals. Imaging began with a similar
ontrast dose in the apical four-chamber view. A minimum
f 15 s of image acquisition was performed after peak
yocardial opacification until disappearance of contrast
rom the myocardium. Imaging was acquired from the
pical two-chamber and apical long axis views using the
ame method.
An independent investigator who had no knowledge of
he clinical and angiographic data interpreted wall motion
nd perfusion using the 16-segment model (1). Studies were
nterpreted as either normal or abnormal in each of the three
oronary arterial territories. A stress-induced contrast defect
as considered present when two contiguous segments
ailed to exhibit contrast enhancement during the washout
f contrast after the bolus injection compared with other
egments at the same depth in the same view, and compared
ith contrast enhancement in the same segment at rest
sing a side-by-side image analysis. Attenuation from con-
rast or lung interference was considered present if any
egment could not be visualized and was not distinguishable
rom surrounding tissue.
Wall motion was scored in each of the 16 segments as
ormal, hypokinetic, akinetic, or dyskinetic. A positive test
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December 7, 2004:2185–91 Stress Echocardiography in Coronary Artery Diseaseor wall motion was defined as new or worsening wall
otion abnormality in two or more contiguous segments
uring stress. The interobserver agreement in our laboratory
s 84% for MCE and 91% for WMA (21). Intraobsever
greement was determined at intermediate and at peak
tress for both WMA and MCE in 30 randomly selected
atients. Results were presented as a percentage with a
orresponding kappa value. To assess the accuracy of the
ndependent reviewer for wall motion analysis of a standard
SE without contrast, 30 randomly selected patients who
nderwent standard DSE using the same infusion protocol
nd who had coronary angiography were evaluated.
The anterior septum, mid-posterior septum, anterior
all, and adjacent apical segments were assigned to the left
nterior descending (LAD) coronary artery, lateral seg-
ents to the left circumflex (LCx) artery, and inferior and
asal septal segments to the right coronary artery (RCA).
he posterior wall was considered an overlap region and was
ssigned to either the LCx or RCA distribution. The apical
nferior/posterior segments were also considered overlap
egions and were assigned to the vascular territory with
ontiguous abnormalities.
uantitative angiography. Coronary angiography was per-
ormed within one month of DSE using the Judkins tech-
ique. Left ventriculography was performed to calculate ejec-
ion fraction. Quantitative measurements of coronary artery
tenosis were made by an experienced interventional cardiolo-
ist (who had no knowledge of DSE results) using a hand-held
lectronic caliper (Tesa SA, Renens, Switzerland) (22). Mea-
urements were expressed as the percent diameter narrowing,
sing the diameter of the nearest normal-appearing region as a
eference. Coronary artery narrowings of 50% and 70%
iameter were both used as cutoff values.
tatistical analysis. Continuous variables were presented
s mean and standard deviation and were compared using
he Student t test. Sensitivity, specificity, and accuracy were
alculated using standard definitions and were presented
ith 95% confidence intervals (CI). Comparison of propor-
ions was made by the chi-square test. A p value 0.05 was
onsidered significant.
ESULTS
oronary angiography. Coronary artery disease (50%
tenosis) was detected in 127 (75%) patients. Among these
atients, 32 had single-vessel, 50 had two-vessel, and 45 had
hree-vessel CAD. The remaining 43 patients had no
ignificant CAD. Coronary artery stenoses involved the
AD in 101 (59%), the RCA in 82 (48%), and the LCx in
4 (49%) patients.
obutamine stress test. Dobutamine-atropine induced
ignificant changes in heart rate and rate pressure product
Table 2). Atropine was administered in 148 (87%) patients
ith a mean dose of 0.6  0.5 mg. Chest pain occurred in
6 (56%) patients and ST-segment depression (0.1 mV
orizontal or downsloping) occurred in 32 (19%) patients. rhe target heart rate was achieved in 143 (84%) patients.
easons for termination of the test in other patients were
evere angina in eight patients, ST-segment changes in four
atients, hypotension in one patient, and severe dyspnea in
ne patient. The test was not terminated because of wall
otion or perfusion abnormalities in any patient.
New or worsening wall motion abnormalities occurred in
00 (59%) patients. Among these patients, 17 (17%) pa-
ients had resting abnormalities as well. New wall motion
bnormalities were observed at intermediate stress in 27
atients. Inducible myocardial perfusion abnormalities oc-
urred in 138 (81%) patients. These abnormalities were
bserved at intermediate stress in 119 (70%) patients. The
ntraobserver agreement on the presence or absence of
eversible perfusion abnormality was 90% at intermediate
tage (Kappa  0.77) and 92% at peak stress (Kappa 
.84). The intraobserver agreement on the presence or
bsence of inducible wall motion abnormality was 93% at
ntermediate stage (Kappa  0.63) and 92% at peak stress
Kappa  0.81).
iagnostic accuracy of MCE and WMA. Inducible myo-
ardial perfusion abnormalities were detected in 116 of 127
atients with a 50% stenosis of 1 coronary artery and in
1 of 43 patients without a significant stenosis. New or
orsening wall motion abnormalities were detected in 89 of
27 patients with 50% stenosis of 1 coronary artery and
n 11 of 43 patients without a significant stenosis. Sensitiv-
ty, negative predictive value, and accuracy of MCE were
ignificantly higher than for WMA. The difference in
ensitivity was more striking at the intermediate stage.
pecificity was higher for WMA (Table 3). The positive
redictive value tended to be higher for WMA, but this
ifference did not reach statistical significance. Coronary
rtery disease was detected in 21 patients who received
efinity and in 106 patients who received Optison. There
as no significant difference between Optison and Definity
ith regard to sensitivity (92%, 95% confidence interval
CI] 0.87 to 0.98 vs. 86%, 95% CI 0.71 to 1.0), specificity
50%, 95% CI 0.33 to 0.67 vs. 56%, 95% CI 0.23 to 0.88),
r accuracy (82%, 95% CI 0.76 to 0.89 vs. 77%, 95% CI
.62 to 0.92).
Diagnostic accuracy of MCE based on the echocardio-
raphic system was 78% for Philips Agilent, 83% for Philips
TL, and 77% for Siemens Acuson Sequoia (p  NS).
Among the 30 randomly selected patients who under-
ent DSE without contrast, CAD was detected by angiog-
able 2. Hemodynamic Data at Different Stages of the
obutamine Stress Test
Stage
Heart Rate
(beats/min)
Rate-Pressure
Product
Dobutamine
Dose
(g/kg/min)
est 74  13 11,473 9,466 0
ntermediate 111  11 16,975 5,715 24 10
eak 144  10 21,373 5,487 32 8aphy in 19. Sensitivity of WMA was 74% (95% CI 0.54 to
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Stress Echocardiography in Coronary Artery Disease December 7, 2004:2185–91.94), specificity was 82% (95% CI 0.59 to 0.97), and
ccuracy was 77% (95% CI 0.62 to 0.92).
etection of multivessel CAD based on multivessel
attern of abnormalities. Inducible perfusion abnormali-
ies occurred more frequently in multivascular regions than
id wall motion abnormalities (44% vs. 18%, p  0.001).
efects were detected in 2 vascular distributions in 64 of
5 patients with multivessel CAD and in 10 of 75 patients
ithout multivessel CAD (sensitivity  67%, 95% CI 58 to
able 3. Overall Accuracy of Myocardial Contrast
chocardiography and Wall Motion Analysis for the Diagnosis
f Coronary Artery Disease (50% Stenosis)
Diagnostic Parameters
Myocardial
Contrast
Wall
Motion p
ensitivity at peak stage 91% (86–96) 70% (62–78) 0.001
ensitivity at intermediate
stage
84% (78–91) 20% (13–27) 0.0001
ensitivity in single-vessel
CAD
81% (68–95) 53% (63–70) 0.001
ensitivity in multi-vessel
CAD
95% (90–99) 76% (66–84) 0.001
pecificity 51% (36–66) 74% (61–88) 0.01
ositive predictive value 85% (79–91) 89% (83–95) 0.09
egative predictive value 67% (59–75) 46% (36–56) 0.02
ccuracy 81% (75–87) 71% (64–78) 0.01
iagnostic parameters are presented as % with corresponding 95% confidence
ntervals.
igure 1. Echocardiographic images from the apical four-chamber and
obutamine stress in a patient with left anterior descending (LAD) and left
vident in the lateral, posterior, and apical segments at intermediate phase with
nducible wall motion abnormalities confined to the apex at peak stress.7; specificity  87%, 95% CI 79 to 94; and accuracy 
6%, 95% CI 70 to 82). New or worsening wall motion
bnormalities were detected in 2 vascular distributions in
7 of the 95 patients with multivessel CAD and in 3 of 75
atients without multivessel CAD (sensitivity  28%, 95%
I 19 to 38, p 0.001; specificity 96%, 95% CI 92 to 99,
 0.05; and accuracy  58%, 95% CI 51 to 66, p 
.001). Figure 1 presents echocardiographic images of a
atient who developed perfusion defects in the LAD and
Cx territories at the intermediate and peak stress stages,
hereas wall motion was abnormal only in the LAD
istribution at peak stress.
egional accuracy. Table 4 presents accuracy of both
echniques for the regional diagnosis of CAD. Sensitivity
nd accuracy of MCE were significantly higher in all
ascular regions. However, the difference in sensitivity was
arger for RCA and LCx compared with the LAD territory.
he majority of perfusion abnormalities occurred at an
ntermediate stage of DSE, often without wall motion
bnormalities, resulting in a larger difference in sensitivities
etween both techniques at an intermediate as compared
ith peak stress. When CAD was defined as a 70%
tenosis, sensitivity improved for each technique in all
ascular regions. MCE maintained a higher sensitivity for
iagnosis of RCA and LCx CAD, whereas sensitivity of
-chamber views, at rest, intermediate stage (Intm), and peak stage of
mflex (LCx) coronary artery disease (CAD). Perfusion abnormalities werethree
circuextension of these abnormalities at peak stress (arrows). The patient had
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December 7, 2004:2185–91 Stress Echocardiography in Coronary Artery Diseaseoth techniques for diagnosis of LAD stenosis was equally
igh (Table 4). Differences in regional sensitivity were
arrower for stenoses 70% (22%) compared with stenoses
etween 50% and 69% (37%) (Fig. 2).
ISCUSSION
n this study, we compared the accuracy of WMA and
CE during DSE for the overall and regional diagnosis of
AD in 170 patients who underwent coronary angiography.
he use of MCE resulted in a significant improvement in
verall and regional sensitivity as well as negative predictive
alue for the diagnosis of CAD. Differences in sensitivity
etween both techniques were larger at the intermediate
hase of the stress test. Although the specificity of WMA
Table 4. Regional Accuracy of Myocardial Con
Analysis for the Diagnosis of Coronary Artery
Arterial Region/Diagnostic Parameter
LAD
Sensitivity at peak stage
Sensitivity at intermediate stage
Sensitivity for 70% stenosis
Specificity
Accuracy
RCA
Sensitivity at peak stage
Sensitivity at intermediate stage
Sensitivity for 70% stenosis
Specificity
Accuracy
LCx
Sensitivity at peak stage
Sensitivity at intermediate stage
Sensitivity for 70% stenosis
Specificity
Accuracy
Pooled sensitivity for stenosis 50%
Pooled sensitivity for stenosis 50–69%
Pooled sensitivity for 70% stenosis
Diagnostic parameters are presented as % with correspondin
igure 2. Pooled regional sensitivities of wall motion analysis and myo-
ardial contrast echocardiography for the diagnosis of coronary stenosesv
etween 50% and 69% and 70%. Solid bars  perfusion; open bars 
all motion.as higher, the overall accuracy and regional accuracy were
ignificantly higher for MCE.
mpact of stress level on the sensitivity. Failure to achieve
he target heart rate has been reported as a cause of false
egative DSE studies in patients with CAD (1,5,8). How-
ver, 10% to 20% of patients still fail to achieve the target
eart rate because of premature termination of the test or
nadequate chronotropic response (1,23). Myocardial perfu-
ion abnormalities on radionuclide imaging have been
etected in patients with CAD in the absence of wall
otion abnormalities at a lower level of dobutamine stress
5,8,24,25).
Our study showed that reversible myocardial perfusion
bnormalities could be detected in patients with CAD by
eal-time MCE. The majority of these abnormalities were
bserved without concomitant wall motion abnormalities at
n earlier stage of the test. These findings would suggest
hat MCE can enhance the sensitivity and accuracy of DSE
n patients who fail to achieve the target heart rate, as well
s in patients in whom the test needs to be prematurely
erminated because of side effects. Our study also empha-
izes the concept of the ischemic cascade during demand
tress in humans, in that inducible myocardial perfusion
bnormalities preceded wall motion abnormalities during
schemia, as has already been shown in animal studies (9).
ecognition of multivessel CAD. Recognition of mul-
ivessel CAD has important therapeutic and prognostic
mplications. Although the majority of patients with mul-
ivessel CAD demonstrate wall motion abnormalities dur-
ng DSE, these abnormalities are frequently localized to one
Echocardiography and Wall Motion
ase in the Three Major Arterial Regions
cardial
trast Wall Motion p
70–86) 63% (53–73) 0.008
51–70) 22% (14–30) 0.0001
78–95) 82% (70–90) NS
62–83) 80% (70–89) 0.09
70–82) 70% (62–77) 0.04
54–75) 33% (23–44) 0.0001
36–59) 8% (4–17) 0.0001
54–81) 43% (29–57) 0.01
82–95) 99% (93–100) 0.004
71–83) 67% (59–74) 0.02
68–86) 37% (27–48) 0.0001
48–70) 12% (5–19) 0.0001
69–91) 42% (40–52) 0.0001
67–86) 97% (89–99) 0.004
74–86) 67% (59–74) 0.002
69–79) 46% (40–52) 0.001
58–76) 30% (21–38) 0.0001
72–85) 57% (49–64) 0.001
confidence intervals.trast
Dise
Myo
Con
78% (
60% (
87% (
72% (
76% (
64% (
47% (
67% (
89% (
77% (
77% (
60% (
80% (
83% (
81% (
74% (
67% (
79% (ascular region (1). The sensitivity of DSE for identifying
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Stress Echocardiography in Coronary Artery Disease December 7, 2004:2185–91ultivessel CAD based on wall motion abnormalities in
ultivascular regions has ranged from 8% to 71% (1). In our
tudy, MCE had a higher sensitivity for recognition of
ultivessel CAD (67% vs. 28%), with only a modestly lower
pecificity (87% vs. 96%) compared with WMA. These
ndings suggest that MCE may be a better method for
valuating the extent of CAD and predicting which patients
ave the largest functional area at risk.
iagnostic accuracy in the three coronary arterial distri-
utions. Previous studies have demonstrated a modest
ensitivity for DSE in diagnosing significant CAD in an
ndividual coronary artery as well as in patients with single-
essel CAD (1–7). In this study, MCE had a significantly
igher sensitivity and accuracy than WMA for the diagnosis
f LAD, RCA, and LCx CAD. The difference in sensitivity
as larger in the RCA and LCx regions. Previous studies
ave also confirmed the lower sensitivity of WMA in
etecting isolated RCA or LCx disease when compared
ith isolated LAD disease (7). One explanation for the
maller differences in LAD sensitivity is the larger myocar-
ial region subtended by LAD, which tends to make the
dentification of WMA less difficult. Leong-Poi et al. (9)
tudied nine dogs that underwent either single- or multives-
el stenosis placement. In single-vessel stenosis, abnormal
erfusion was seen at the lowest dose of dobutamine
rrespective of the stenosis severity, whereas a wall motion
bnormality was seen only at high doses of dobutamine and
as influenced by the stenosis severity. The spatial extent of
bnormal perfusion exceeded that of the wall motion ab-
ormality at all but the highest dobutamine dose. Thus, the
nhanced regional sensitivity we observed with MCE may
e due to both the earlier occurrence of a perfusion defect
nd the greater size of any induced perfusion defect.
mpact of coronary artery stenosis severity. When CAD
as redefined as 70% stenosis, sensitivity was enhanced
or both techniques in all arterial regions. Sensitivity of
CE remained higher than that of WMA for the diagnosis
f LCx and RCA disease, whereas sensitivities for LAD
AD were no different. Pooled results in the three arterial
egions showed a higher sensitivity for MCE for stenoses
etween 50% and 69% as well as for stenoses 70%.
owever, differences in regional sensitivity were smaller for
tenoses 70% compared with stenoses between 50% and
9%. These data, as well as previous published reports,
ndicate that perfusion abnormalities during stress occur
ith less severe stenosis diameters than those that induce
all motion abnormalities (26,27). Animal studies have
onfirmed this phenomenon by demonstrating that dobut-
mine induces capillary derecruitment distal to a noncritical
oronary stenosis, and that graded coronary stenoses result
n a progressive reduction of myocardial blood flow ratios
hile wall thickening remains normal (28,29).
tudy limitations. Coronary angiography was performed
ccording to the discretion of the treating physician and not
er study protocol. The study patients represented only 13%
f patients who underwent DSE. Therefore, results are aeavily biased toward the selection process. This may
xplain the higher prevalence of CAD in the study patients
nd the lower specificity of MCE, because ischemia was
ore frequently detected by MCE, leading to more verifi-
ation bias in association with perfusion abnormalities.
The lower specificity of MCE could also be due to
rtifactual defects in the apical and basal segments due to
ear field destruction and lung interference (30). Also, it is
ossible that impairment of vasodilator reserve may occur in
he absence of a significant major coronary arterial narrow-
ng. Although wall motion analysis was performed with the
id of contrast-enhanced border detection, which increases
he number of segments that can be analyzed during DSE
31), the use of frame rates between 25 and 30 Hz may have
ecreased the ability of the reviewer to detect tardokinesis as
sign of ischemia (32).
Patients in this study had a high pre-test probability of
AD, reflected by 75% prevalence. This possibly contrib-
ted to a high sensitivity of MCE. The sensitivity of MCE
ay be lower in a population with lower disease prevalence.
Two different MCE agents were used, with potential
ifferences in bubble concentration. However, adjustments
ere made in the dose administered to account for these
ifferences, and a separate analysis of both agents revealed
o difference in the diagnostic accuracy.
We used a small bolus injection technique to analyze
yocardial perfusion. Unlike a continuous infusion of mi-
robubbles, a bolus injection may have greater attenuation
nd will not be able to quantify myocardial blood flow
hanges (33). Most investigators consider the infusion
ethod as the ideal way to achieve a “steady-state” micro-
ubble concentration in the cavity pool and thus a constant
nput function. This also avoids the cavity attenuation that
ay occur when bolus injections are used at the higher
ardiac outputs during staged dobutamine/atropine studies.
owever, with the very small bolus injections used in this
tudy, we reduced the attenuation that occurs from left
entricular cavity contrast and had feasible image interpre-
ation in 95% of patients. It is more likely that the majority
f the attenuation problems were related to the low me-
hanical index pulse sequence schemes used for real-time
maging. Although a continuous infusion could potentially
ave improved the detection of coronary stenoses during
obutamine infusion, the reductions in myocardial blood
olume alone from a coronary stenosis were sufficient to
roduce a significant improvement in accuracy using a
imple bolus injection technique.
UMMARY AND CONCLUSIONS
eal-time MCE improves the sensitivity and accuracy of
SE for the overall and regional diagnosis of CAD com-
ared with WMA. The majority of reversible perfusion
bnormalities in patients with CAD occur at the interme-
iate phase of the stress test, often without wall motion
bnormalities, emphasizing the concept of an ischemic
c
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CE will be particularly useful in patients who cannot
chieve the target heart rate. The sensitivity of MCE is
igher for detection of multivessel CAD based on abnor-
alities in 2 arterial regions, which can potentially im-
rove the identification of high-risk patients. The findings
f our study suggest that MCE should be the preferred
ethod whenever the patient is anticipated not to achieve
he target heart rate and in patients in whom the benefit of
ery high sensitivity outweighs the disadvantage of lower
pecificity, such as those with a pre-test probability of CAD
igher than 50%. Future studies are needed to determine
hether MCE can improve the prognostic value of DSE.
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